3654 results for «221»

Filter By

3654 results

Addressing remaining issues after TAVI: what to expect from the new generation?

21 Nov 2023 – From PCR London Valves 2023

Consult this session if you want to discuss the challenges of TAVI for lower-risk patients, and to capture the features of new TAVI devices.

Addressing remaining issues after TAVI: what to expect from the new generation?

TAVI in cardiogenic shock

19 Nov 2023 – From PCR London Valves 2023

Because TAVI implantation, a routine procedure, is not always a breeze, look at a number of challenging cases, including a case of aortic stenosis complicated by cardiogenic shock, an emergency valve-in-valve TAVI, or a TAVI for left ventricular assist device.

TAVI in cardiogenic shock

Controversies in atrioventricular valves - The Heart Team ring, Vol II

19 Nov 2023 – From PCR London Valves 2023

This session offers an opportunity to engage in a real case discussion led by an advanced Heart Team. Participate in discussions on controversial decision-making scenarios and stay informed about the latest clinical evidence related to MitraClip, Tendyne, and TriClip therapies.

Controversies in atrioventricular valves

Tricuspid valve interventions - Case studies

19 Nov 2023 – From PCR London Valves 2023

Explore a diverse range of tricuspid valve interventions through various case studies such as the multimodality percutaneous treatment of severe tricuspid regurgitation, Triclip subacute single leaflet detachment, bicaval valve implantation and more.

TAVI in complex scenarios

19 Nov 2023 – From PCR London Valves 2023

What do we mean by "complex scenarios"? When zero-contrast TAVI implantation becomes a good alternative in kidney disease, when TAVI is implanted in a patient with mechanical mitral valve, or when TAVI is implanted in very large annulus with subannular aneurysm, for example!

TAVI in complex scenarios

Late-breaking trials on latest-generation aortic valves and dedicated transcatheter devices

20 Nov 2023 – From PCR London Valves 2023

Find out the outcomes of the main studies on the latest-generation valves and devices presented at PCR LV 2023 to better determine their benefits, performance and interest in the treatment of specific aortic pathologies: REACCESS-2 Study, ACURATE Neo2 PMCF post-market registry, OCEAN-TAVI registry, ShortCut Pivotal Study, and...

Late-breaking trials on latest-generation aortic valves and dedicated transcatheter devices

Mitral valve interventions in challenging clinical situations

21 Nov 2023 – From PCR London Valves 2023

Discover innovative approaches to mitral valve interventions in challenging clinical situations: navigate the challenges of critical stenosis in a bioprosthetic mitral valve, learn more about the use of iVAC-2L in transcatheter edge-to-edge repair for a mitral valve lacking leaflet coaptation, explore mitral transcutaneous edge-to-edge repair guided by transthoracic...

Mitral valve interventions in challenging clinical situations

TAVI - Coronary protection strategies

20 Nov 2023 – From PCR London Valves 2023

Consult this session for key insights into diverse coronary protection approaches: get a look at the management of a complex case involving a degenerated aortic bioprosthesis and paravalvular leak, observe a successful TAVI in calcified bicuspid anatomy with low coronaries, delve into a case featuring a degenerated...

TAVI - Coronary protection strategies

SWISS-APERO: a randomized trial of the amulet versus watchman FLX devices for left atrial appendage closure

04 Nov 2021

The SWISS-APERO is a prospective, investigator-initiated, randomized, multi-center, and clinical trial designed to compare the Amulet and Watchman (2.5 and FLX) devices in a head-to-head fashion.

Francesco Costa

Author

Francesco Costa
SWISS-APERO: a randomized trial of the amulet versus watchman FLX devices for left atrial appendage closure

Post-TAVI cardiac arrest associated to acute coronary occlusion: facing the storm to gain calm

26 Jan 2024

Observe this TAVI case featuring pulseless electrical activity due to an unforeseen acute occlusion of the right coronary artery, and discover the strategies employed to address and resolve this critical complication.

Authors :

Juan Guzmán Olea, Gonzalo Tolosa Dzul, Beatriz Villegas González, Jonathan Uribe González,  Guillermo Arenas Fonseca, Tomás Herrera Arzola, Rosa Gutiérrez Castañeda, Víctor Sustaita Cerda, Raúl Cruz Palomera, Arely Méndez Mercado, Darío Valencia González, Carlos Javier González Álvarez, Héctor Hugo Escutia Cuevas, Daniel Iván Pérez Vásquez, Gabriel Guzmán Olea.Specialty Hospital, Puebla, IMSS, México
Post-TAVI cardiac arrest associated to acute coronary occlusion: facing the storm to gain calm

Mid-term echocardiographic outcomes following transapical mitral valve replacement: Updates from the Intrepid Pilot Study

19 Sep 2022

Pamela Gatto provides her take on the Intrepid Global Pilot Study which was presented by Renuka Jain at TCT Congress 2022.

Pamela Gatto

Author

Pamela Gatto
Updates from the Intrepid Pilot Study: Mid-term Echocardiographic Outcomes Following Transapical Mitral Valve Replacement

ALL-RISE: A large-scale, global randomized trial of coronary physiology derived from conventional angiography compared with an invasive pressure wire-based approach to guide PCI

28 Mar 2026

Mirvat Al Asnag provides her take on the ALL-RISE randomised trial presented by Ajay J. Kirtane at ACC.26 in New Orleans.

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
A large-scale, global randomized trial of coronary physiology derived from conventional angiography compared with an invasive pressure wire-based approach to guide percutaneous coronary intervention

Five-year clinical and echocardiographic outcomes from the PARTNER 3 Low-Risk randomized trial

26 Oct 2023

Alex Sticchi provides his take on the 5-year outcomes from PARTNER 3 Low Risk which were presented by Martin B. Leon at TCT Congress 2023.

Alessandro Sticchi

Author

Alessandro Sticchi
Five-Year Clinical and Echocardiographic Outcomes from The PARTNER 3 Low-Risk Randomized Trial

Intravascular ultrasound-guided or angiography-guided complex high-risk PCI – The IVUS CHIP trial

28 Mar 2026

Daniele Giacoppo reports and provides his perspective on the main results of the IVUS-CHIP trial, presented by Roberto Diletti from the Erasmus University Medical Center, Rotterdam, the Netherlands, during a Late-Breaking Trials session at the ACC.26 in New Orleans, and simultaneously published in the New England Journal of...

Daniele Giacoppo

Author

Daniele Giacoppo
Intravascular ultrasound guidance for complex high-risk indicated procedures – The Ivus Chip trial
Didn’t find what you were looking for?